CIK 0001650664
- Non-accelerated filer
- Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464097528
- Phone
- +1 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $89,088
- in 5 filings, $89K under 10b5-1 plans
Net −$89,088. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-03-15 | Glucksmann Alexandra Chief Operating Officer | Exercise or conversion | +1,000 | $0.65 | $650 | 118,788 |
| 2017-03-15 | Glucksmann Alexandra Chief Operating Officer | Sale | −1,000 | $26.41 | $26K | 117,788 |
| 2017-03-15 | Glucksmann Alexandra Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) | −1,000 | 30,461 | ||
| 2017-02-15 | Glucksmann Alexandra Chief Operating Officer | Exercise or conversion | +6,000 | $0.65 | $4K | 123,788 |
| 2017-02-15 | Glucksmann Alexandra Chief Operating Officer | Sale | −5,000 | $20.00 | $100K | 118,788 |
| 2017-02-15 | Glucksmann Alexandra Chief Operating Officer | Sale | −1,000 | $23.48 | $23K | 117,788 |
| 2017-02-15 | Glucksmann Alexandra Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) | −6,000 | 31,461 | ||
| 2016-08-23 | Glucksmann Alexandra Chief Operating Officer | Exercise or conversion | +1,000 | $0.65 | $650 | 118,788 |
| 2016-08-23 | Glucksmann Alexandra Chief Operating Officer | Sale | −1,000 | $20.00 | $20K | 117,788 |
| 2016-08-23 | Glucksmann Alexandra Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) | −1,000 | 37,461 |
Page 1 of 1 · 10 trades